A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines

Resource type
Journal Article
Authors/contributors
Title
A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines
Abstract
Epstein-Barr Virus (EBV) diseases, including EBV-associated post-transplant lymphoproliferative disorder (PTLD) remain important causes of morbidity and mortality in children undergoing solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT). Despite progress in the prevention of EBV disease including PTLD (EBV/PTLD) in HCT, key questions in the prevention, and management of these infectious complications remain unanswered. The goal of this manuscript is to highlight key points and recommendations derived from the consensus guidelines published by the International Pediatric Transplant Association and the European Conference on Infections in Leukemia for children undergoing SOT and HCT, respectively. Additionally, we provide background and guidance on the use of EBV viral load measurement in the prevention and management of these children.
Publication
Journal of the Pediatric Infectious Diseases Society
Volume
13
Issue
Supplement_1
Pages
S31-S38
Date
2024-02-01
Journal Abbr
Journal of the Pediatric Infectious Diseases Society
ISSN
2048-7207
Short Title
A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients
Accessed
3/17/24, 10:21 AM
Library Catalog
Silverchair
Citation
Yamada, M., L’Huillier, A. G., & Green, M. (2024). A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines. Journal of the Pediatric Infectious Diseases Society, 13(Supplement_1), S31–S38. https://doi.org/10.1093/jpids/piad097
SOLID ORGANS AND MCSS
HEME-ONC AND CELLULAR THERAPIES
Link to this record